Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts - PubMed (original) (raw)

Effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts

Xuan Wang et al. Cell Mol Neurobiol. 2008 Jan.

Abstract

Our previous studies have demonstrated that ciliary neurotrophic factor, a member of the interleukin-6-type cytokine superfamily, could inhibit the differentiation of myoblasts into mature myotubes at a certain concentration. In this study, another two members, interleukin-6 and leukemia inhibitory factor, together with ciliary neurotrophic factor were tested their roles in the proliferation and differentiation of myoblasts derived from the adult human skeletal muscles, in order to confirm that these cytokines might be a new type of regulatory factors on the myoblasts. The results showed that the effects of interleukin-6, leukemia inhibitory factor, and ciliary neurotrophic factor on the proliferation and differentiation of adult human myoblasts were different. Leukemia inhibitory factor in the dose of 10 ng/ml could accelerate the cell proliferation. Leukemia inhibitory factor in the dose of 10 or 50 ng/ml and ciliary neurotrophic factor in the dose of 10 or 50 ng/ml could inhibit the myoblast differentiation. The inhibition mechanism might be that leukemia inhibitory factor and ciliary neurotrophic factor inhibited the expressions of transcription factor MyoD/myf5, which could regulate the myoblast differentiation. This study will provide the experimental and theoretic foundations for the basic and clinical researches about human myoblasts.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Comp Neurol. 2005 Oct 17;491(2):96-108 - PubMed
    1. Dev Biol. 2000 Feb 15;218(2):115-24 - PubMed
    1. J Cell Biol. 1994 Jun;125(6):1275-87 - PubMed
    1. Cell. 2000 Dec 22;103(7):1099-109 - PubMed
    1. Stem Cells. 2003;21(1):5-14 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources